Journal of the American Academy of Dermatology

Diseases, Conditions, Syndromes

Serlopitant found to be safe, effective for chronic pruritus

(HealthDay)—Serlopitant has potential as a therapy for the treatment of chronic pruritus, according to a study published in the May issue of the Journal of the American Academy of Dermatology.

Oncology & Cancer

Hydrochlorothiazide tied to non-melanoma skin cancer risk

(HealthDay)—Use of the diuretic hydrochlorothiazide is associated with a substantially increased risk of non-melanoma skin cancer, according to a study published in the April issue of the Journal of the American Academy ...

Oncology & Cancer

Guidelines of care developed for skin cancer management

(HealthDay)—Guidelines of care have been developed for the management of basal cell carcinoma (BCC) and cutaneous squamous cell carcinoma (cSCC), according to two reports published online Jan. 10 in the Journal of the American ...

Oncology & Cancer

Hydrochlorothiazide may up basal, squamous cell cancer risk

(HealthDay)—Hydrochlorothiazide use is associated with an increased risk of non-melanoma skin cancer (NMSC), with evidence of a dose-response relationship, according to a study published online Dec. 3 in the Journal of ...

Diseases, Conditions, Syndromes

Racial minorities less likely to see a doctor for psoriasis

Despite the fact that their disease may be more severe, a new study shows minorities are less likely than white Americans to see a doctor for psoriasis treatment. Researchers from the Perelman School of Medicine at the University ...

Diseases, Conditions, Syndromes

Obesity may be tied to higher rosacea risk in women

(HealthDay)—Obesity may be associated with an increased risk for rosacea, according to a study published in the December issue of the Journal of the American Academy of Dermatology.

page 9 from 25